SUSQUEHANNA INTERNATIONAL GROUP, LLP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 66 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$331,559
+50.6%
142,300
+53.8%
0.00%
Q2 2023$220,150
+207.2%
92,500
+137.5%
0.00%
Q1 2023$71,662
+4.8%
38,947
+8.2%
0.00%
Q4 2022$68,406
+163.1%
36,003
+196.6%
0.00%
Q3 2022$26,000
-66.2%
12,140
-55.2%
0.00%
Q2 2022$77,000
-58.2%
27,117
-38.6%
0.00%
Q1 2022$184,000
-79.6%
44,200
-74.6%
0.00%
Q4 2021$900,000
+26.9%
173,740
+60.4%
0.00%
Q3 2021$709,000108,3000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders